MENU
STOK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Stoke Therapeutics (STOK) Earnings Date & Reports
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine... Show more
A.I. Advisor
published Earnings
STOK is expected to report earnings to fall 1.57% to -91 cents per share on November 10
Q3'26
Est.
$-0.92
Q2'26
Missed
by $0.16
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.23
Q3'25
Missed
by $0.07
The last earnings report on August 03 showed earnings per share of -93 cents, missing the estimate of -76 cents. With 190.70K shares outstanding, the current market capitalization sits at 1.65B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a company, which engages in the research and development of treatments for genetic diseases.
Industry Biotechnology
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
170
Web
https://www.stoketherapeutics.com